Status:
TERMINATED
CICERO- A Care Home Study of COVID-19
Lead Sponsor:
Queen Mary University of London
Conditions:
COVID
Eligibility:
All Genders
18-130 years
Phase:
NA
Brief Summary
The primary objective of the study is to determine whether, at 21 days, care homes that implemented near-patient daily testing have a lower rate of confirmed CoV-2 infections than care homes following...
Detailed Description
Accurate, rapid, near-patient testing systems, such as q16+CoV-2, allow for daily routine testing of residents, and of staff and visitors prior to entering the care home. Daily CoV-2 PCR testing with...
Eligibility Criteria
Inclusion
- Persons resident or requiring access to the care home
- Capable of giving written informed consent, or if appropriate, having an acceptable individual capable of giving consent on the participant's behalf.
Exclusion
- Persons not providing informed consent or withdrawing consent at any time during the study.
- Persons requiring urgent and immediate access to the care home, for example medical staff attending emergency visits.
- Persons unable to provide nasal or oropharyngeal swabs for medical reasons.
Key Trial Info
Start Date :
July 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2020
Estimated Enrollment :
461 Patients enrolled
Trial Details
Trial ID
NCT04453553
Start Date
July 2 2020
End Date
October 27 2020
Last Update
August 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary University London
London, United Kingdom, E1 2ES